Combined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cells

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 5, 2010, Pages

  Taylor, Matthew D ^a   Liu, Yuan ^a   Nagji, Alykhan S ^a   Theodosakis, Nicholas ^a   Jones, David R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZ; BORTEZOMIB; UNCLASSIFIED DRUG; UVOMORULIN; VORINOSTAT;

ARTICLE; CANCER CELL; CELL INVASION; CONTROLLED STUDY; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 77950909402     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.01.039     Document Type: Article

References (25)

1. Cui W., Fowlis D.J., Bryson S., Duffie E., Ireland H., Balmain A., et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86 (1996) 531-542
2. Derynck R., Akhurst R.J., and Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29 (2001) 117-129
3. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2 (2002) 442-454
4. Denlinger C.E., Keller M.D., Mayo M.W., Broad R.M., and Jones D.R. Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer. J Thorac Cardiovasc Surg 127 (2004) 1078-1086
5. Yoshikawa M., Hishikawa K., Marumo T., and Fujita T. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-β1 in human renal epithelial cells. J Am Soc Nephrol 18 (2007) 58-65
6. Hosler M.R., Wang-Su S.T., and Wagner B.J. Role of the proteasome in TGF-β signaling in lens epithelial cells. Invest Ophthalmol Vis Sci 47 (2006) 2045-2052
7. Mayo M.W., Denlinger C.E., Broad R.M., Yeung F., Reilly E.T., Shi Y., et al. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-κ B through the Akt pathway. J Biol Chem 278 (2003) 18980-18989
8. Liu Y., Smith P.W., and Jones D.R. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol Cell Biol 26 (2006) 8683-8696
9. Smith P.W., Liu Y., Siefert S.A., Moskaluk C.A., Petroni G.R., and Jones D.R. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer. Cancer Lett 276 (2009) 196-203
10. Del Duca D., Werbowetski T., and Del Maestro R.F. Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion. J Neurooncol 67 (2004) 295-303
11. Guo H.B., Lee I., Kamar M., and Pierce M. N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways. J Biol Chem 278 (2003) 52412-52424
12. Wijnhoven B.P., Dinjens W.N., and Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 87 (2000) 992-1005
13. Lin D.C., Du X.L., and Wang M.R. Protein alterations in ESCC and clinical implications: a review. Dis Esophagus 22 (2009) 9-20
14. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg 192 (2001) 708-718
15. Zhao X.J., Li H., Chen H., Liu Y.X., Zhang L.H., Liu S.X., et al. Expression of e-cadherin and β-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. World J Gastroenterol 9 (2003) 225-232
16. Falkenback D., Nilbert M., Oberg S., and Johansson J. Prognostic value of cell adhesion in esophageal adenocarcinomas. Dis Esophagus 21 (2008) 97-102
17. Kelly W.K., Richon V.M., O'Connor O., Curley T., MacGregor-Curtelli B., Tong W., et al. Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. Clin Cancer Res 9 (2003) 3578-3588
18. Lu C., Gallegos R., Li P., Xia C.Q., Pusalkar S., Uttamsingh V., et al. Investigation of drug-drug interaction potential of bortezomib in vivo in female Sprague-Dawley rats and in vitro in human liver microsomes. Drug Metab Dispos 34 (2006) 702-708
19. von Burstin J., Eser S., Paul M.C., Seidler B., Brandl M., Messer M., et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology 137 (2009) 361-371 371.e1-5
20. Sunwoo J.B., Chen Z., Dong G., Yeh N., Crowl Bancroft C., Sausville E., et al. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κ B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res 7 (2001) 1419-1428
21. Saitoh M., Shirakihara T., and Miyazono K. Regulation of the stability of cell surface E-cadherin by the proteasome. Biochem Biophys Res Commun 381 (2009) 560-565
22. Foitzik K., Paus R., Doetschman T., and Dotto G.P. The TGF-β2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol 212 (1999) 278-289
23. Wu Y., Evers B.M., and Zhou B.P. Small C-terminal domain phosphatase enhances snail activity through dephosphorylation. J Biol Chem 284 (2009) 640-648
24. Blumenberg M., Gao S., Dickman K., Grollman A.P., Bottinger E.P., and Zavadil J. Chromatin structure regulation in transforming growth factor-β-directed epithelial-mesenchymal transition. Cell Tissues Organs 185 (2007) 162-174
25. Pitts T.M., Morrow M., Kaufman S.A., Tentler J.J., and Eckhardt S.G. Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models. Mol Cancer Ther 8 (2009) 342-349